Anadrol 25 - Canada Peptides

Oxymetholone was introduced by Syntex in the early 1960s as Anadrol-50, originally intended for treatment of underweight disorders, osteoporosis, and chronic anemia. Its unparalleled anabolic potency made it highly effective for stimulating weight gain and red blood cell production. However, its strong estrogenic activity—despite being a DHT derivative—resulted in water retention, gynecomastia, and hypertension. Over time, its clinical use narrowed due to concerns over hepatotoxicity, though it was briefly revived in the late 1990s for AIDS-related wasting.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Anadrol 25 by Canada Peptides, consult with your doctor or healthcare professional.